During exposure to chemotherapeutics or targeted therapies, we observed the consistent upregulation of SETDB1 and SETDB2 in melanoma, lung and colon cancer-derived cell lines, which indicates a common role for both proteins following drug exposure [15]. Here, SETDB1 is linked to melanoma.